Last time around, it was 238-194. So while the Democrats picked up 30 seats, embryonic stem-cell research funding picked up only 15 votes. If the issue is so powerful, shouldn’t the second number be higher than the first?
Share this story

About the Author
Ramesh Ponnuru is the editor of National Review, a columnist for the Washington Post, and a fellow at the American Enterprise Institute.
Advertisement
Advertisement





Comments